Published in Endocrinology on September 21, 2016
Melatonin, mitochondria, and the metabolic syndrome. Cell Mol Life Sci (2017) 0.75
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care (1999) 26.39
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes (2003) 16.62
Metformin. N Engl J Med (1996) 7.66
Transplanted suprachiasmatic nucleus determines circadian period. Science (1990) 5.55
High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab (2007) 4.93
A circadian gene expression atlas in mammals: implications for biology and medicine. Proc Natl Acad Sci U S A (2014) 4.22
Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) (2012) 4.04
Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med (2011) 3.88
Circadian timing of food intake contributes to weight gain. Obesity (Silver Spring) (2009) 3.44
Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med (2012) 3.08
Melatonin secretion and the incidence of type 2 diabetes. JAMA (2013) 2.65
Inactivation of specific β cell transcription factors in type 2 diabetes. J Clin Invest (2013) 2.18
Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet (2012) 2.15
Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin. Diabetes (2009) 2.10
Healthy clocks, healthy body, healthy mind. Trends Cell Biol (2009) 1.95
Evidence for a circadian rhythm of insulin secretion. Am J Physiol (1996) 1.86
Functional assessment of pancreatic beta-cell area in humans. Diabetes (2009) 1.82
Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Lancet (2008) 1.72
Within-subject variability of measures of beta cell function derived from a 2 h OGTT: implications for research studies. Diabetologia (2007) 1.67
Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab (2004) 1.66
Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes (2014) 1.62
Increased Melatonin Signaling Is a Risk Factor for Type 2 Diabetes. Cell Metab (2016) 1.55
Time and time again: the phylogeny of melatonin as a transducer of biological time. J Biol Rhythms (1997) 1.54
Melatonin as a chronobiotic. Sleep Med Rev (2005) 1.50
Persistent rotating shift-work exposure accelerates development of metabolic syndrome among middle-aged female employees: a five-year follow-up. Chronobiol Int (2009) 1.40
Shift work: coping with the biological clock. Occup Med (Lond) (2010) 1.38
Activation of 5'-AMP-activated kinase with diabetes drug metformin induces casein kinase Iepsilon (CKIepsilon)-dependent degradation of clock protein mPer2. J Biol Chem (2007) 1.35
Bmal1 and β-cell clock are required for adaptation to circadian disruption, and their loss of function leads to oxidative stress-induced β-cell failure in mice. Mol Cell Biol (2013) 1.22
Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels? Br J Cancer (2004) 1.18
Detrimental effects of constant light exposure and high-fat diet on circadian energy metabolism and insulin sensitivity. FASEB J (2013) 1.17
Temporal changes in pancreatic islet composition in C57BL/6J-db/db (diabetes) mice. Diabetologia (1983) 1.17
Prevalence of sleep disturbances in diabetes mellitus. Diabetes Res Clin Pract (1994) 1.16
Neural control of the pineal gland. Behav Brain Res (1996) 1.15
Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes. Am J Physiol Endocrinol Metab (2000) 1.14
Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res (2010) 1.14
Consequences of exposure to light at night on the pancreatic islet circadian clock and function in rats. Diabetes (2013) 1.12
Melatonin: both master clock output and internal time-giver in the circadian clocks network. J Physiol Paris (2011) 1.09
The role of clock genes in pharmacology. Annu Rev Pharmacol Toxicol (2010) 1.08
The effects of light at night on circadian clocks and metabolism. Endocr Rev (2014) 1.07
Human circadian rhythms: physiological and therapeutic relevance of light and melatonin. Ann Clin Biochem (2006) 1.04
Ramelteon (TAK-375) accelerates reentrainment of circadian rhythm after a phase advance of the light-dark cycle in rats. J Biol Rhythms (2005) 1.04
Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J Pineal Res (2006) 1.04
Clock gene expression in peripheral leucocytes of patients with type 2 diabetes. Diabetologia (2008) 1.00
Nutritionally induced insulin resistance and receptor defect leading to beta-cell failure in animal models. Ann N Y Acad Sci (1999) 0.99
Circadian desynchrony and metabolic dysfunction; did light pollution make us fat? Med Hypotheses (2011) 0.98
Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan. Cell Metab (2016) 0.95
Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening. Sleep (2014) 0.92
Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials. Vasc Health Risk Manag (2011) 0.92
Clinical pharmacokinetics of melatonin: a systematic review. Eur J Clin Pharmacol (2015) 0.89
Roles and regulation of the transcription factor CREB in pancreatic β -cells. Curr Mol Pharmacol (2011) 0.89
Does disruption of circadian rhythms contribute to beta-cell failure in type 2 diabetes? Curr Diab Rep (2014) 0.89
A Smartphone App Reveals Erratic Diurnal Eating Patterns in Humans that Can Be Modulated for Health Benefits. Cell Metab (2015) 0.89
Daily rhythms of plasma melatonin, but not plasma leptin or leptin mRNA, vary between lean, obese and type 2 diabetic men. PLoS One (2012) 0.88
Circadian rhythm in the serotonin content of the rat pineal gland: regulating factors. J Pharmacol Exp Ther (1967) 0.85
Bmal1 is required for beta cell compensatory expansion, survival and metabolic adaptation to diet-induced obesity in mice. Diabetologia (2016) 0.84
Circadian Disruption and Diet-Induced Obesity Synergize to Promote Development of β-Cell Failure and Diabetes in Male Rats. Endocrinology (2015) 0.84
Dim light at night exaggerates weight gain and inflammation associated with a high-fat diet in male mice. Endocrinology (2013) 0.83
Circadian actions of melatonin at the suprachiasmatic nucleus. Behav Brain Res (1996) 0.83
Activation of Melatonin Signaling Promotes β-Cell Survival and Function. Mol Endocrinol (2015) 0.82
The islet circadian clock: entrainment mechanisms, function and role in glucose homeostasis. Diabetes Obes Metab (2015) 0.82
The melatonin agonist ramelteon induces duration-dependent clock gene expression through cAMP signaling in pancreatic INS-1 β-cells. PLoS One (2014) 0.81
Effect of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist, on motor performance in mice. Neurosci Lett (2006) 0.81
Common type 2 diabetes risk variant in MTNR1B worsens the deleterious effect of melatonin on glucose tolerance in humans. Metabolism (2015) 0.80
Potential use of melatonin as adjunct antihypertensive therapy. Am J Hypertens (2005) 0.76
Various patterns of disrupted daily rest-activity rhythmicity associated with diabetes. J Sleep Res (2016) 0.76